Using a decision tree analysis, this surprising reduction in serum CBS levels (Figure 5) was found to predict MS disease activity, and specifically RRMS disease activity, with 82% and 75% predictive accuracy, respectively. The gene discussed is CBS; the disease is myeloid sarcoma.